Crossmark

Synergistic effects of colistin-based combinations against colistin and carbapenem-resistant Klebsiella pneumoniae isolated from nosocomial bloodstream infections

Crossref DOI link: https://doi.org/10.1038/s41598-025-21822-9

Published Online: 2025-10-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pourabbas, Bahman

Sepehrpour, Shima

Asaei, Sadaf

Abbasian, Amin

Pourabbas, Parham

Rezaei, Zahra
License Information

Text and Data Mining valid from 2025-10-30

Version of Record valid from 2025-10-30
More Information

Article History

Received: 23 June 2025

Accepted: 24 September 2025

First Online: 30 October 2025

Declarations

:

: The authors declare no competing interests.

: This study received ethical approval from the Ethics Committee of Professor Alborzi Clinical Microbiology Research Center and from the Ethics Committee of Shiraz University of Medical Sciences (SUMS), Shiraz, Iran (Approval Code: IR.SUMS.REC.1401.618). As this was a retrospective study using anonymized clinical data, the requirement for informed consent was waived by the same Ethics Committees in accordance with national guidelines and institutional policies.

: All experiments were carried out in accordance with the relevant guidelines.

Document is current

Any future updates will be listed below